APUS 2.11 ▲ 8.76% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Apimeds Pharmaceuticals U...

    NYSE: APUS · Real-Time Price · USD
    2.11
    0.17 (8.76%)
    At close: Sep 12, 2025, 3:59 PM
    2.04
    -3.32%
    After-hours: Sep 12, 2025, 07:36 PM EDT
    8.76%
    Bid 2.08
    Market Cap 26.52M
    Revenue (ttm) n/a
    Net Income (ttm) -3.71M
    EPS (ttm) -0.36
    PE Ratio (ttm) -5.86
    Forward PE n/a
    Analyst n/a
    Ask 2.11
    Volume 294,994
    Avg. Volume (20D) 108,146
    Open 1.98
    Previous Close 1.94
    Day's Range 1.98 - 2.19
    52-Week Range 1.37 - 4.00
    Beta n/a

    About APUS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol APUS
    Website n/a
    Full Company Profile
    news image

    2 weeks ago · businesswire.com

    Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

    MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of Alaba...

    news image

    2 months ago · businesswire.com

    Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

    MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical-stage biopharmaceutical company developing Apitox, an intradermally admi...

    Add to Watchlist